关注
Sohini Chakraborti
标题
引用次数
引用次数
年份
Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility
A Maitra, MC Sarkar, H Raheja, NK Biswas, S Chakraborti, AK Singh, ...
Journal of Biosciences 45, 1-18, 2020
1242020
Increasing the bioactive space of peptide macrocycles by thioamide substitution
H Verma, B Khatri, S Chakraborti, J Chatterjee
Chemical Science 9 (9), 2443-2451, 2018
692018
Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data
S Chakraborti, S Bheemireddy, N Srinivasan
Molecular Omics, 2020
412020
NU-6027 inhibits growth of Mycobacterium tuberculosis by targeting protein kinase D and protein kinase G
S Kidwai, R Bouzeyen, S Chakraborti, N Khare, S Das, T Priya Gosain, ...
Antimicrobial agents and chemotherapy 63 (9), 10.1128/aac. 00996-19, 2019
312019
Desolvation of peptide bond by O to S substitution impacts protein stability
B Khatri, S Raghunathan, S Chakraborti, R Rahisuddin, S Kumaran, ...
Angewandte Chemie International Edition 60 (47), 24870-24874, 2021
152021
Identification of potential binders of Mtb Universal Stress Protein (Rv1636) through an in silico approach and insights into compound selection for experimental validation
S Chakraborti, M Chakraborty, A Bose, N Srinivasan, SS Visweswariah
Frontiers in Molecular Biosciences 8, 177, 2021
152021
An amide to thioamide substitution improves the permeability and bioavailability of macrocyclic peptides
P Ghosh, N Raj, H Verma, M Patel, S Chakraborti, B Khatri, ...
Nature communications 14 (1), 6050, 2023
142023
Drug repurposing approach targeted against main protease of sars-cov-2 exploiting ‘neighbourhood behaviour’in 3d protein structural space and 2d chemical space of small molecules
S Chakraborti, N Srinivasan
102020
In silico modeling of FDA-approved drugs for discovery of anticandida agents: A drug-repurposing approach
S Chakraborti, G Ramakrishnan, N Srinivasan
In silico drug design, 463-526, 2019
102019
Repurposing drugs based on evolutionary relationships between targets of approved drugs and proteins of interest
S Chakraborti, G Ramakrishnan, N Srinivasan
Computational Methods for Drug Repurposing, 45-59, 2019
102019
'All That Glitters Is Not Gold': High-Resolution Crystal Structures of Ligand-Protein Complexes Need Not Always Represent Confident Binding Poses
S Chakraborti, K Hatti, N Srinivasan
International Journal of Molecular Sciences 22 (13), 6830, 2021
82021
A ligand-centric approach to identify potential drugs for repurposing: Case-study with Aurora Kinase inhibitors
S Chakraborti, PS Chakravarthi, N Srinivasan
Drug Repurposing in Cancer Therapy: Approaches and Applications, 15, 2020
82020
Protein structure, dynamics and assembly: Implications for drug discovery
A Yazhini, S Chakraborti, N Srinivasan
Innovations and Implementations of Computer Aided Drug Discovery Strategies …, 2021
72021
NOD: a web server to predict New use of Old Drugs to facilitate drug repurposing.
SC TJ Narwani, N Srinivasan
Scientific Reports 11, 13540, 2021
62021
SBDD and Its Challenges
S Chakraborti, S Sachchidanand
Current Trends in Computational Modeling for Drug Discovery, 1-24, 2023
12023
Computational Methods and Tools for Repurposing of Drugs Against Coronaviruses
S Chakraborti, S Bheemireddy, N Srinivasan
In Silico Modeling of Drugs Against Coronaviruses: Computational Tools and …, 2021
12021
A New Beginning to the Existing Medicines; Repurposing FDA-Approved Drugs for the Neglected Re-Emerging Disease Leptospirosis
SAD Christie, S Hariharan, S Chakraborti, N Srinivasan, MG Madanan
ACS omega 9 (30), 32717-32726, 2024
2024
School of Life Sciences Research Jigsaw Puzzles
N Stanley-Wall, A Cameron, E Hardee, A Davies, A Prescott, P Harrison, ...
2024
Protein-small molecule interactions: Structural insights and applications in computational drug discovery
S Chakraborti
2021
系统目前无法执行此操作,请稍后再试。
文章 1–19